Page 4,297«..1020..4,2964,2974,2984,299..4,3104,320..»

Skills Like Walking, Talking Don't Come Easily for Minority Kids With Autism

Posted: Published on May 7th, 2014

By Amy Norton HealthDay Reporter TUESDAY, May 6, 2014 (HealthDay News) -- Minority children with autism are more likely to have lost critical developmental skills, such as walking or talking, than are white children, according to a new study. The phenomenon, called developmental regression, occurs when children have reached milestones such as saying words and walking, and then those skills suddenly vanish. The new research found that the odds of developmental regression were twice as high for black children and 1.5 times higher for Hispanic children than they were for white youngsters. It's estimated that one-third of children with autism go through developmental regression, said lead researcher Dr. Adiaha Spinks-Franklin, of Baylor College of Medicine and Texas Children's Hospital in Houston. "They learn to babble or talk, then stop. They learn to play patty-cake, then stop," said Spinks-Franklin. This appears to be the first study to show racial disparities in rates of developmental regression. And for now, the cause is unclear, Spinks-Franklin said. No one knows why regression happens at all, said Dr. Dan Coury, medical director for the Autism Speaks Autism Treatment Network. "But it does make us wonder if it might be a different type of autism, with … Continue reading

Comments Off on Skills Like Walking, Talking Don't Come Easily for Minority Kids With Autism

Connection between epilepsy and autism may expand treatment options for epileptics

Posted: Published on May 7th, 2014

By Megdad M. Zaatreh, M.D. I t is estimated that nearly 33 percent of people with autism spectrum disorder also have epilepsy. But until recently there had been little clinical research about the connection between the two neurological conditions. Epilepsy is a brain disorder marked by recurring seizures or convulsions.Autism is a neurobehavioral disease that includes impairment in social interaction and language development, which often includes rigid, systematic repetitive behaviors. Both conditions can affect patients with varying degrees of severity. New research has found that adults with epilepsy are more likely to show signs of autism and Asperger syndrome. Up to this point, in many cases, epileptic adults may not have been properly diagnosed or treated for autism symptoms. The connection between the two conditions was the result of a study that showed epileptic seizures short-circuit the neurological function that affects socialization in the brain, which are the same traits seen in autism.These characteristics include impairment of normal social interaction (eye contact, conversation, enjoying the act of sharing with someone else) and tightly regimented or repetitive cycles of behavior. Shedding new light onto socialization challenges for epileptics Up to now, the social and behavioral challengers for some people with epilepsy … Continue reading

Comments Off on Connection between epilepsy and autism may expand treatment options for epileptics

Sean Savitz discusses revolutionizing stroke treatment, CCAM 2014 – Video

Posted: Published on May 7th, 2014

Sean Savitz discusses revolutionizing stroke treatment, CCAM 2014 Sean Savitz, M.D., associate professor of neurology at UT Health Science Center-Houston, discusses revolutionizing the treatment of strokes with a mobile str... By: UTSystemVideo … Continue reading

Comments Off on Sean Savitz discusses revolutionizing stroke treatment, CCAM 2014 – Video

Time is Crucial in Stroke Treatment | Jay Howington, M.D. | Memorial Health Savannah – Video

Posted: Published on May 7th, 2014

Time is Crucial in Stroke Treatment | Jay Howington, M.D. | Memorial Health Savannah Jay Howington, M.D., of Memorial Health in Savannah, Georgia, talks about the importance of rapid stroke treatment. Learn more at: http://memorialhealth.com/... By: Memorial Health … Continue reading

Comments Off on Time is Crucial in Stroke Treatment | Jay Howington, M.D. | Memorial Health Savannah – Video

Innovative Neurosurgery Led to Stroke Patient's Remarkable Recovery

Posted: Published on May 7th, 2014

Contact Information Available for logged-in reporters only Newswise DALLAS May 7, 2014 Tom Guynes considers himself a living miracle. Hes been treated for a typically fatal form of fast-spreading cancer, congestive heart failure, and a hernia all in the past two years. So when he suffered a stroke the morning of Nov. 24, 2013, both he and his wife Nan feared the worst. Im just thankful that I came here, Mr. Guynes said. The people at UTSouthwestern Medical Center have done wonders, and I think my life has been saved several times here. Mr. Guynes, 68, of Farmersville, Texas, credits the fast action and coordination of the stroke team at UTSouthwestern with minimizing damage to his brain from the stroke and, most importantly, saving his life. The perfect harmony of rapid evaluation, testing, and expert treatment for Mr. Guynes stroke that took place that day put into action protocols developed as part of UTSouthwesterns recent certification as an Advanced Comprehensive Stroke Center, the first and only such center in North Texas. This recognition by The Joint Commission is the highest level of certification for stroke care. His treatment also utilized a new telemedicine program in which UTSouthwestern specialists advise partner … Continue reading

Comments Off on Innovative Neurosurgery Led to Stroke Patient's Remarkable Recovery

Exenatide has potential as disease modifying agent in Parkinson's disease

Posted: Published on May 7th, 2014

A follow-up study of patients with Parkinson's disease (PD) who participated in an earlier "proof of concept" clinical trial using exenatide showed that improvements persisted twelve months after discontinuing exenatide therapy. These data provide strong encouragement for the further study of this drug in patients with PD, report researchers in the Journal of Parkinson's Disease. Several recent discoveries have highlighted common cellular pathways that potentially relate neurodegenerative processes with abnormal mitochondrial function and abnormal glucose metabolism. Exenatide, a glucagon-like peptide-1 agonist (GLP-1 agonist) medication marketed as Byetta and Bydureon and used in the treatment of insulin resistance in patients with Type 2 diabetes, has been proposed as a disease modifying drug in PD. Earlier studies had shown that exenatide is neuroprotective and promotes functionally beneficial neuroplasticity in animal models of neurodegeneration. Furthermore, exenatide has a favorable safety profile, with only relatively mild gastrointestinal side effects (including nausea and weight loss) as frequent adverse events. In an earlier "proof of concept" randomized controlled trial published in May 2013, participants were randomized to either self-administer exenatide in addition to their regular PD medications or to act as controls, i.e., receive their conventional PD treatment only. All of the participants had moderate severity … Continue reading

Posted in Parkinson's Treatment | Comments Off on Exenatide has potential as disease modifying agent in Parkinson's disease

Social workers can help patients recover from mild traumatic brain injuries

Posted: Published on May 7th, 2014

More than a million people are treated for mild traumatic brain injuries in U.S. hospitals and emergency rooms each year. Yet few receive appropriate psychological and social follow-up care that can make the difference in whether or not they fully recover. A University of Washington researcher has found that a 20-minute conversation with a social worker has the potential to significantly reduce the functional decline of those diagnosed with a mild traumatic brain injury. The research is published in the April issue of Brain Injury. Megan Moore in the UW's School of Social Work is training social workers in emergency departments to provide education and resources to patients with mild traumatic brain injuries to help them deal with symptoms and the recovery process. "Social workers are masters-level trained clinicians who are already embedded in emergency room treatment teams," Moore said. "The goal of my work is to provide them with specialized training on mild traumatic brain injuries to help bridge the psychological and social aspects of treatment with medical care." Traumatic brain injury occurs when the head is hit by an outside force, causing the brain to move rapidly within the skull, altering consciousness and damaging the nervous system. Anyone … Continue reading

Posted in Brain Injury Treatment | Comments Off on Social workers can help patients recover from mild traumatic brain injuries

Study: Concussion recovery longer for men than women

Posted: Published on May 7th, 2014

Suffering a concussion can be a different experience for everyone and now, new imaging research has revealed that the recovery process may actually be more difficult for one gender than the other. In a new study published online in the journal Radiology, researchers from the University of Pittsburgh utilized diffusion tensor imaging (DTI) on concussion patients to determine how males and females recover from injury. Their scans revealed that males may take longer to overcome a concussion also known as a mild traumatic brain injury (mTBI) than females with similar injuries. According to the researchers, these findings indicate that DTI could be used to provide more tailored treatment for concussions in the future. Currently, its difficult to determine which patients will have a smoother recovery from concussion, as opposed to those who will struggle. The thing that got us curious is you see differences [in concussion recovery] between males and females all the time, Dr. Saeed Fakhran, assistant professor of neuroradiology at the University of Pittsburgh School of Medicine. We wanted to know: Is it a gender difference or something else? No one had really looked at the imaging, so we didnt even know there would be a difference. Approximately … Continue reading

Posted in Brain Injury Treatment | Comments Off on Study: Concussion recovery longer for men than women

Engineering Resilience in the Brain, Elastic Properties, Train Tracks and Crossties

Posted: Published on May 7th, 2014

Engineering Resilience in the Brain, Elastic Properties, Train Tracks and Crossties With hundreds of billions of neurons, each with its own inner world of organelles and molecular components, understanding the fundamental wiring of the brain is a major undertaking, one that has received a commitment of at least $100 million worth of federal funding from the National Science Foundation (NSF), the National Institutes of Health and the Defense Advanced Research Projects Agency. And with all of the brain's interconnected structures, protecting or repairing this complicated machine means thinking like an engineer. Shenoy applies this approach to a problem very much in the public eye--traumatic brain injury. Even the mildest forms of TBI, better known as concussions, can do irreversible damage to the brain. More serious forms can be fatal. With a background in mechanical engineering and materials science, one might think that Shenoy's contribution to this problem involves designing new helmets or other safety devices. Instead, he and his colleagues are uncovering the fundamental math and physics behind one of the core mechanisms of the injury: swelling in axons caused by damage to internal structures known as microtubules. These neural "train tracks" transport molecular cargo from one end of a … Continue reading

Posted in Brain Injury Treatment | Comments Off on Engineering Resilience in the Brain, Elastic Properties, Train Tracks and Crossties

Earnings Roundup: Biogen's Tecfidera Wins More Share

Posted: Published on May 7th, 2014

Biogen (NASDAQ: BIIB) remains a market leader in treating multiple sclerosis, an autoimmune disease that affects more than 1.1 million people in the U.S. and Europe. The company has launched a host of widely successful MS therapies over the past decade, including blockbuster Avonex and Tysabri. However, competition in the form of oral drugs from Novartis (NYSE: NVS) and Sanofi (NYSE: SNY) have cut into Avonex's market share. Given that Biogen has responded to that competitive threat with its own oral drug, Tecfidera, let's take a closer look at the company's first-quarter results. BIIB data by YCharts A big, global market According to Express Scripts, spending on MS medication is going to grow roughly 12% a year through 2016. That's solid growth given that MS is unfortunately already the second most costly specialty drug category, costing insurers more than $46 per member per year in 2013. The market share leader in MS treatment is Teva's (NYSE: TEVA) Copaxone, an injectible therapy that loses patent protection next month. Teva has been battling to keep generic biosimilars from Mylan and Momenta at bay. The Supreme Court recently decided it would hear Teva's case, which may insulate it from the generic threat a … Continue reading

Posted in MS Treatment | Comments Off on Earnings Roundup: Biogen's Tecfidera Wins More Share

Page 4,297«..1020..4,2964,2974,2984,299..4,3104,320..»